Biological markers of disease activity in inflammatory bowel diseases

Biological markers of disease activity in inflammatory bowel diseases

Inflammatory bowel diseases (IBD) are chronic intestinal conditions of multifactorial aetiology including genetic susceptibility, immunological impairment, dysbiosis, and environmental factors. The diagnosis is based on both clinical and endoscopic features, wherein histopathological evaluation rema...

Full description

Bibliographic Details
Main Authors:	Edyta Szymanska, Sylwia Szymanska, Maciej Dadalski, Jaroslaw Kierkus
Format:	Article
Language:	English
Published:	Termedia Publishing House 2023-07-01
Series:	Gastroenterology Review
Subjects:	inflammatory bowel disease biomarkers zonulin faecal calprotectin elafin haptoglobin.
Online Access:	https://www.termedia.pl/Biological-markers-of-disease-activity-in-inflammatory-bowel-diseases,41,51066,1,1.html

Similar Items

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
by: Edyta Szymanska, et al.
Published: (2021-08-01)

The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study
by: Edyta Szymanska, et al.
Published: (2023-01-01)

Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
by: Stanislav Naryzhny, et al.
Published: (2021-06-01)

Intestinal Permeability and Depression in Patients with Inflammatory Bowel Disease
by: Miorita Melina Iordache, et al.
Published: (2022-08-01)

Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients
by: Iulia Soare, et al.
Published: (2021-08-01)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
by: Mariusz A. Bromke, et al.
Published: (2021-05-01)

Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease
by: Rayna Shentova, et al.
Published: (2020-06-01)

Faecal calprotectin – a useful tool in the management of inflammatory bowel disease
by: Emanuel Burri, et al.
Published: (2012-03-01)

Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs
by: Eugenia Veronica Di Brizzi, et al.
Published: (2022-11-01)

Predictive value of faecal calprotectin in ulcerative colitis – single centre experience
by: Dora Grgić, et al.
Published: (2022-12-01)

Safety and efficacy of vedolizumab in pediatric inflammatory bowel disease with emphasis on the very-early-onset group
by: Sylwia Fabiszewska, et al.
Published: (2023-06-01)

Sexual functions in individuals with inflammatory bowel diseases
by: Marta Kotkowicz-Szczur, et al.
Published: (2023-03-01)

Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases
by: Sylwia Fabiszewska, et al.
Published: (2021-07-01)

The association of zonulin-related proteins with prevalent and incident inflammatory bowel disease
by: Xiao Wang, et al.
Published: (2022-01-01)

Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity
by: Agata Anna Cisek, et al.
Published: (2024-01-01)

Assessing vitamin D as a biomarker in inflammatory bowel disease
by: Fiona Yeaman, et al.
Published: (2023-12-01)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
by: Jin-Tong Shi, et al.
Published: (2023-02-01)

Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease
by: Joana Franco Lacerda, et al.
Published: (2021-02-01)

Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series
by: Roberto Trasolini, et al.
Published: (2022-01-01)

New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
by: Vincent Castiglione, et al.
Published: (2022-09-01)

The role of biomarkers in early diagnostics of inflammatory diseases of intestine in newborns
by: Chernenkov Yu.V., et al.
Published: (2017-06-01)

The role of fecal calprotectin in investigating inflammatory bowel diseases
by: Mustafa Erbayrak, et al.
Published: (2009-05-01)

The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
by: Marlijne C. G. de Graaf, et al.
Published: (2022-12-01)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
by: Hui Won Jang, et al.
Published: (2016-10-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

Application of faecal calprotectin as marker of gastrointestinal tract disorders
by: Magdalena Trzepizur, et al.
Published: (2021-09-01)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
by: Soheila Moein, et al.
Published: (2017-06-01)

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study
by: Edyta Szymanska, et al.
Published: (2021-07-01)

A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
by: Gonzalo Hijos-Mallada, et al.
Published: (2023-01-01)

Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease
by: Marko Kumric, et al.
Published: (2021-12-01)

Clinico-endoscopic and biochemical parallels of chronic inflammatory bowel diseases with positive inflammatory markers
by: Yu.M. Stepanov, et al.
Published: (2022-12-01)

Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice
by: A. A. Sheptulin, et al.
Published: (2023-05-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

Usefulness of Colon Assessment by Magnetic Resonance Enterography in Pediatric Patients with Inflammatory Bowel Disease—Retrospective Case Series
by: Joanna Sieczkowska-Golub, et al.
Published: (2021-09-01)

The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
by: Bianca J. Galgut, et al.
Published: (2018-01-01)

Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01)

Haptoglobin and Its Related Protein, Zonulin—What Is Their Role in Spondyloarthropathy?
by: Magdalena Chmielińska, et al.
Published: (2021-03-01)

Zonulin and blood–brain barrier permeability are dissociated in humans
by: Charlotte M. Stuart, et al.
Published: (2022-07-01)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-06-01)

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
by: N Waugh, et al.
Published: (2013-11-01)